Latest News
02ndSeptember, 2016
Mundipharma strengthens its consumer healthcare business with 50+ country deal for HiGeen® with Munir Sukhtian Group
HiGeen® treatments complement Mundipharma’s existing consumer healthcare portfolio, which includes the BETADINE® range Partnership to increases access to the HiGeen® range of treatments for...
01stSeptember, 2016
Mundipharma Named “2016 Best Employer Singapore”
Singapore 1 September, 2016: Singapore-based pharmaceuticals company, Mundipharma, has been named Best Employer Singapore by AON Hewitt, a global leader in human resource solutions. First awarded...
25thAugust, 2016
Experts at World Congress of Internal Medicines reinforce importance of BETADINE® in disease prevention, infection cont...
New in-vitro studies demonstrate BETADINE® medicines containing Povidone-Iodine (PVP-I) have a rapid virucidal kill rate against MERS coronavirus Using antiseptics in infection control can...
30thJune, 2016
Multinational ADOPT Study Seeks Further Improvement in Management of Oral Mucositis
Achieving optimal management of oral mucositis will improve the wellbeing of patients undergoing cancer treatment Singapore, 27 June 2016 – A new study titled ADOPT (Awareness Drives Oral...
17thJune, 2016
Mundipharma’s Raman Singh listed among top five in global Power List following a blockbuster year
SINGAPORE, 15 June 2016 – Raman Singh, President, Mundipharma Asia Pacific, Latin America, the Middle East and Africa, has been ranked the world’s fourth most influential person in the...
09thJune, 2016
New In-Vitro Studies Reinforce Efficacy of BETADINE® Skin Cleanser against Viruses that cause Hand Foot & Mouth Di...
SINGAPORE, 7 June 2016 – New in-vitro research shows that the BETADINE® skin cleanser kills 99.99% of the leading strains of Hand Foot & Mouth Disease (HFMD), a viral infection that is...
